Artelo Biosciences
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
505 Lomas Santa Fe Dr Ste 160, Solana Be...Phone Number
(858) 925-7049Website
www.artelobio.comRevenue
-Stock Symbol
ARTLIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Artelo Biosciences
Artelo Biosciences is a clinical stage pharmaceutical company founded in 2011 that focuses on research and development of proprietary therapeutics targeting lipid-signaling pathways, including the endocannabinoid system. The company develops product candidates addressing unmet medical needs in conditions such as anorexia, cancer, anxiety, pain, and inflammation. Artelo Biosciences applies scientific, regulatory, and commercial expertise to develop therapeutic solutions. As a publicly traded company, Artelo maintains multiple research locations to advance its pharmaceutical development programs.Explore more
Artelo Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artelo Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Artelo Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Artelo Biosciences
Funding: Get notified immidiatlly once Artelo Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Artelo Biosciences is spiking on competitors!
Product Launch: Get notified when Artelo Biosciences launches new products
Click to see if Artelo Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Artelo Biosciences recently announced quarterly report
Check if Artelo Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Artelo Biosciences
Compare insights from companies similar to Artelo Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artelo Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Artelo Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Artelo Biosciences.
Artelo Biosciences financials insights
Gather financial insights about Artelo Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$1.4M
Stock/Share Issuance
$9.5M
2026
Multiple Rounds
$11.8M
Artelo Biosciences Tech Stack
A closer look at the technologies used by Artelo Biosciences
Most Recent Scoops
Person-Based
Medical Research
Funding
Funding
Funding
Funding
Funding
Funding
Funding
Funding
Artelo Biosciences News & Media
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
SOLANA BEACH, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced that the Japanese Patent Office has issued a notification of allowance with a Decision to Grant for the Company’s patent application covering the intended commercial formArtelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
The Patent Claims are for the Intended Commercial Formulation of ART27.13Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming MilestonesArtelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artelo Biosciences
Sign Up For FreeTo access detailed company insights
Artelo Biosciences is a clinical stage pharmaceutical company founded in 2011 that focuses on research and development of proprietary therapeutics targeting lipid-signaling pathways, including the endocannabinoid system. The company develops product candidates addressing unmet medical needs in conditions such as anorexia, cancer, anxiety, pain, and... Read More
